Bionano Genomics logo

Bionano Genomics

BNGO | NASDAQ
Chart Builder DCF Calculator
$0.94
-$0.06 (-6.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
+$0.05 (+5.32%)
After-hours: Nov 16, 2026, 7:51 PM ET
-6.00%

Rating

Updated: Nov 14, 2026
49.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #282/1021 (Top 28%)

Key Statistics

Market Data

Market Cap $13.14M
1D Range
0.93 1.00
52W Range
0.93 1.85

Valuation (TTM)

PE -0.35
PB 0.47
EV/EBITDA -0.67

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $5.00
Loading financial charts...

Profile

Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analy...

Sector Healthcare
Employees 96
IPO Date Aug 21, 2018
Website bionano.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.54
Miss -20.00%
REV
$8.28M
Miss -1.98%
Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+431.91%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.